CE and FDA approved Troponin I/Myoglobin/CK-MB test kits

FOB Reference Price:Get Latest Price
US $0.65-2 / Pieces | 1000 Piece/Pieces (Min. Order)
Report Suspicious Activity
Quick Details
Pathological Analysis Equipments
Brand Name:
Place of Origin:
Zhejiang, China (Mainland)
Model Number:
CE/FDA/ ISO9001/ ISO13485
lateral flow test
Reading time:
10 minutes
MYO Sensitivity:
CKMB Sensitivity:
cTNI Sensitivity:
2 to 30 Centigrade
Expiration date:
24 months
Supply Ability
Supply Ability:
500000 Piece/Pieces per Month
Packaging & Delivery
Packaging Details
1 piece/ pouch, 40 pcs/box, 1000pcs/carton, Carton size:63*37*30cm
Lead Time :
within 3 weeks

Intended Use of Cardiac Markers Combo Rapid Test Device

The Cardiac Markers Combo Rapid Test Device (Whole Blood/Serum/Plasma) is a rapid visual immunoassay for the qualitative presumptive detection of human Myoglobin, CKMB and cardiac Troponin I in whole blood, serum or plasma. This kit is intended for use as an aid in the diagnosis of myocardial infarction (MI).


Knowledge of Cardiac Markers Combo Rapid Test Device

Myoglobin (MYO), Creatine Kinase MB (CK-MB) and cardiac Troponin I (cTnI) are proteins released into the bloodstream after cardiac injury. Myoglobin is a heme-protein normally found in skeletal and cardiac muscle with a molecular weight of 17.8 kDa. It constitutes about 2 percent of total muscle protein and is responsible for transporting oxygen within muscle cells. When muscle cells are damaged, Myoglobin is released into the blood rapidly due to its relatively small size. The level of Myoglobin increases measurably above baseline within 2-4 hours post-infarct, peaking at 9-12 hours, and returning to baseline within 24-36 hours. CKMB is an enzyme also present in the cardiac muscle, with a molecular weight of 87.0 kDa. Creatine Kinase is a dimeric molecule formed from two subunits designated as M and B, which combine to form three different isoenzymes, CKMM, CKBB and CKMB. CKMB is the isoenzyme of Creatine Kinase most involved in the metabolism of cardiac muscle tissue. The release of CK-MB into the blood following an MI can be detected within 3-8 hours after the onset of symptoms. It peaks within 9 to 30 hours, and returns to baseline levels within 48 to 72 hours. Cardiac Troponin I is a protein found in cardiac muscle, with a molecular weight of 22.5 kDa. Troponin I is part of a three subunit complex comprised of Troponin T and Troponin C. Along with tropomyosin, this structural complex forms the main component that regulates the calcium sensitive ATPase activity of actomyosin in striated skeletal and cardiac muscle. After cardiac injury occurs, Troponin I is released into the blood 4-6 hours after the onset of pain. The release pattern of Troponin I is similar to CK-MB, but while CK-MB levels return to normal after 72 hours, Troponin I remains elevated for 6-10 days, thus providing for a longer window of detection for cardiac injury.


Procedure and Result Reading of Cardiac Markers Combo Rapid Test Device




Product Image of Cardiac Markers Combo Rapid Test Device